Primary regulatory
AOD-9604 Clinical Trial Registry Entries: ClinicalTrials.gov
ClinicalTrials.gov registry search for AOD-9604 clinical trials, including the Phase 2 obesity program by Metabolic Pharmaceuticals that failed to meet primary weight loss endpoints. AOD-9604 is not FDA-approved.
ClinicalTrials.gov / U.S. National Library of MedicinePublished 2026-07-01Accessed 2026-07-01
Registry record
Source metadata
- Publisher
- ClinicalTrials.gov / U.S. National Library of Medicine
- Source type
- Primary regulatory
- Registry ID
clinicaltrials-gov-aod-9604
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.